Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose PK/PD study of a novel PEGylated interferon mutant injection in healthy volunteers
CTR20231168Phase 2Active
- Sponsor
- 三元基因
- Start
- Apr 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated interferon alpha in viral hepatitis, sponsored by 三元基因. Started Apr 2023; status: active.
02
Drugs
pegylated interferon alpha
03
Conditions
viral hepatitis
Beyond the preview
Go deeper on CTR20231168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231168.